Results 61 to 70 of about 36,296 (116)

Assessment of the therapeutic potential of Hsp70 activator against prion diseases using in vitro and in vivo models. [PDF]

Front Cell Dev Biol
Zayed M, Kim YC, Jeong BH.
europepmc   +1 more source

Efficient transmission of human prion diseases to a glycan-free prion protein-expressing host. [PDF]

Brain
Cracco L, Cali I, Cohen ML, Aslam R, Notari S, Kong Q, Newell KL, Ghetti B, Appleby BS, Gambetti P.   +9 more
europepmc   +1 more source

Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases. [PDF]

Acta Neuropathol
Zhang W, Orrú CD, Foutz A, Ding M, Yuan J, Shah SZA, Zhang J, Kotobelli K, Gerasimenko M, Gilliland T, Chen W, Tang M, Cohen M, Safar J, Xu B, Hong DJ, Cui L, Hughson AG, Schonberger LB, Tatsuoka C, Chen SG, Greenlee JJ, Wang Z, Appleby BS, Caughey B, Zou WQ.   +25 more
europepmc   +1 more source

Multisite Skin Biopsies vs Cerebrospinal Fluid for Prion Seeding Activity in the Diagnosis of Prion Diseases.

JAMA Neurol
Chen ZY, Shi Q, Xiao K, Kong Y, Liang DL, Wang YH, Min R, Zhang J, Wang Z, Ye H, Gao R, Chu M, Nan HT, Jiang DM, Li JJ, Wang L, Zou WQ, Wu LY, Dong XP.   +18 more
europepmc   +1 more source

Different reactive profiles of calmodulin in the CSF samples of Chinese patients of four types of genetic prion diseases. [PDF]

Front Mol Neurosci
Jia XX, Hu C, Chen C, Gao LP, Liang DL, Zhou W, Cao RD, Xiao K, Shi Q, Dong XP.   +9 more
europepmc   +1 more source

Novel method for classification of prion diseases by detecting PrP^res signal patterns from formalin-fixed paraffin-embedded samples. [PDF]

Prion
Koyama S, Yagita K, Hamasaki H, Noguchi H, Shijo M, Matsuzono K, Takase KI, Kai K, Aishima SI, Itoh K, Ninomiya T, Sasagasako N, Honda H.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prion Diseases

Current Biology, 1992
There have been remarkably rapid advances in the understanding of prion diseases over the past year. The controversial notion that the transmissible agent may be an abnormal isoform of a host-encoded protein, the prion protein, is now gaining wide acceptance.
J, Collinge, M S, Palmer
openaire   +2 more sources

Prion Diseases

Journal of Neurovirology, 2003
Prion diseases are incurable neurodegenerative conditions affecting both animals and humans. They may be sporadic, infectious, or inherited in origin. Human prion diseases include Creutzfeldt-Jakob desease (CJD), Gerstmann-Straussler-Scheinker disease, kuru, and fatal familial insomnia.
Edward, McKintosh, Sarah J, Tabrizi, John, Collinge   +2 more
openaire   +2 more sources

Prion diseases

Haemophilia, 1998
Summary. Although the nature of the infectious agent causing prion diseases is still debated, several of its molecular characteristics have been clarified in remarkable detail. The transmissibility of bovine spongiform encephalopathy to humans dramatically highlights the need for research focused at interference with prion replication and spread, and ...
C. A. Lee, C. M. Kessler, D. Varon, U. Martinowitz, M. Heim, A. AGUZZI, C. WEISSMANN   +6 more
openaire   +3 more sources

Prion Disease

Seminars in Neurology, 2019
AbstractPrion diseases are a phenotypically diverse set of disorders characterized by protease-resistant abnormally shaped proteins known as prions. There are three main groups of prion diseases, termed sporadic (Creutzfeldt–Jakob disease [CJD], sporadic fatal insomnia, and variably protease-sensitive prionopathy), genetic (genetic CJD, fatal familial ...
Kelly J, Baldwin, Cynthia M, Correll
openaire   +2 more sources